{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:47:56Z","timestamp":1772106476299,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T00:00:00Z","timestamp":1325721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029068","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T08:52:52Z","timestamp":1325839972000},"page":"e29068","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Alexander B.","family":"Opoku-Acheampong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle K.","family":"Nelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Unis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Lindshield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,1,5]]},"reference":[{"key":"ref1","year":"2011"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.urology.2004.04.084","article-title":"Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.","volume":"64","author":"GL Andriole","year":"2004","journal-title":"Urology"},{"issue":"22","key":"ref3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/jnci\/93.22.1687","article-title":"Androgen receptor signaling in androgen-refractory prostate cancer.","volume":"93","author":"ME Grossmann","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.bi.63.070194.000325","article-title":"Steroid 5 alpha-reductase: Two genes\/two enzymes.","volume":"63","author":"DW Russell","year":"1994","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1677\/erc.1.00914","article-title":"In situ androgen producing enzymes in human prostate cancer.","volume":"12","author":"Y Nakamura","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pros.10284","article-title":"Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: Implications for finasteride therapy of prostate carcinoma.","volume":"57","author":"J Luo","year":"2003","journal-title":"Prostate"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1158\/1078-0432.CCR-04-0738","article-title":"Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.","volume":"11","author":"MA Titus","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ref8","first-page":"855","article-title":"Messenger ribonucleic acid levels of steroid 5 alpha-reductase 2 in human prostate predict the enzyme activity.","volume":"86","author":"TG Soderstrom","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"ref9","first-page":"2210","article-title":"Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissue.","volume":"82","author":"C Bjelfman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5\u20136","key":"ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0960-0760(99)00030-8","article-title":"Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue.","volume":"68","author":"C Iehle","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"ref11","first-page":"1815","article-title":"The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.","volume":"9","author":"F Habib","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"ref12","first-page":"S31","article-title":"Comparison of clinical trials with finasteride and dutasteride.","volume":"6","author":"JC Nickel","year":"2004","journal-title":"Reviews in Urology"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/j.1939-4640.1991.tb00274.x","article-title":"Overview of enzyme inhibitors and anti-androgens in prostatic cancer.","volume":"12","author":"J Geller","year":"1991","journal-title":"J Androl"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer.","volume":"349","author":"IM Thompson","year":"2003","journal-title":"N Engl J Med"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer.","volume":"362","author":"G Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"ref16","article-title":"FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer."},{"issue":"13","key":"ref17","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1158\/1078-0432.CCR-06-0184","article-title":"Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.","volume":"12","author":"Y Xu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/0008-5472.CAN-06-3462","article-title":"Combinations of tomato and broccoli enhance antitumor activity in dunning R3327-H prostate adenocarcinomas.","volume":"67","author":"K Canene-Adams","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pros.2990090306","article-title":"Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.","volume":"9","author":"JT Isaacs","year":"1986","journal-title":"Prostate"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.1041","article-title":"Human cell lines as an in vitro\/in vivo model for prostate carcinogenesis and progression.","volume":"47","author":"MM Webber","year":"2001","journal-title":"Prostate"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/carcin\/18.6.1215","article-title":"Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.","volume":"18","author":"D Bello","year":"1997","journal-title":"Carcinogenesis"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e10423","DOI":"10.1371\/journal.pone.0010423","article-title":"Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.","volume":"5","author":"BL Lindshield","year":"2010","journal-title":"PLoS One"},{"issue":"21","key":"ref23","first-page":"4956","article-title":"Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.","volume":"56","author":"GT Klus","year":"1996","journal-title":"Cancer Res"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pros.10340","article-title":"Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.","volume":"58","author":"CB Lazier","year":"2004","journal-title":"Prostate"},{"issue":"23","key":"ref25","first-page":"6630","article-title":"Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.","volume":"60","author":"BJ Long","year":"2000","journal-title":"Cancer Res"},{"issue":"16","key":"ref26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/pros.21028","article-title":"Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone.","volume":"69","author":"JPM Sedelaar","year":"2009","journal-title":"Prostate"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0022-4731(79)90092-X","article-title":"Steroid levels in cancer of the prostate-markers of tumour differentiation and adequacy of anti-androgen therapy.","volume":"11","author":"J Geller","year":"1979","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"13","key":"ref28","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1158\/1078-0432.CCR-05-0525","article-title":"Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.","volume":"11","author":"MA Titus","year":"2005","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1677\/ERC-10-0022","article-title":"Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.","volume":"17","author":"K Das","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/pros.20637","article-title":"Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.","volume":"68","author":"Y Song","year":"2008","journal-title":"Prostate"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.HYP.34.4.920","article-title":"Gender differences in hypertension in spontaneously hypertensive rats: Role of androgens and androgen receptor.","volume":"34","author":"JF Reckelhoff","year":"1999","journal-title":"Hypertension"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/j.1939-4640.1993.tb01657.x","article-title":"Effects of finasteride on the rat ventral prostate.","volume":"14","author":"TC Shao","year":"1993","journal-title":"J Androl"},{"issue":"18","key":"ref33","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1073\/pnas.88.18.8044","article-title":"Feed-forward control of prostate growth: Dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.","volume":"88","author":"FW George","year":"1991","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T05:41:20Z","timestamp":1713332480000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029068"}},"subtitle":[],"editor":[{"given":"Ming Tat","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029068","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,5]]}}}